Thursday , May 23 2019


Cancer is one of the world’s most pressing health care challenges. On the whole, research progress from one year to the next is incremental, and true breakthroughs are exceptional.

Nevertheless, every year brings new knowledge and insights that help direct further research and ultimately improve the outlook for patients with cancer. Clinical Cancer Advances 2017 highlights the most important clinical advances of the past year and previews where cancer science is headed.

Advances highlighted in this report cover the full range of clinical research disciplines: prevention, treatment, patient care, and tumor biology.

“What is new in oncology 2017?

Landmark studies, new drug approvals, practice changing information will be discussed

150 oncologist from India and abroad will be coming for this meeting at Hotel Turyaa ,OMR, Chennai, between 12 noon to 9 pm.

Key meeting agenda

  1. Newer approach to cancer with immunotherapy has revolutionized the world and can be used in all cancers like Pembroluzumab , Nivolumab , Aleclituzumab etc
  1. Breast cancer has seen several newer drugs and targeted therapy Pertuzumab , TDM 1 , which has improved survival .
  1. Survival in Lung cancer has increased with newer molecular classification and more specific targeted drugs.
  1. Colon cancer even in last stage patient has a survival of 36 months atleast with several lines of newer drugs.
  1. Robotic surgery has evolved with sophisticated instruments will be shown as video,
  1. New proton beam which is coming to Chennai will have a demonstration tonight the latest technology in Radiation oncology.
  1. blood cancers has changed in scenario with many monoclonal antibodies to treat leukaemia and myelomas in adult and paediatrics.
  1. Psychosocial aspects of cancer patients with supportive care will be addressed by specialist
  1. Incorporation of yoga and Allied health medicine is now an emerging integral part of Oncology.
  1. India is the hub of clinical trials. What changes has taken place and where are we heading for clinical trials in India.
  1. India is one of the highest manufactures of Biosimilars and chemotherapeutic drugs. We are having medical affairs from pharmaceutical companies to discuss.
  1. Pharmaco-economics and GST we have special delegation from New Delhi to talk on this.
  1. Advancement in Oncopathology and onco radiology is a part of the session
  1. The childhood cancer most curable have we achieved the target.

Prof Dr Anita Ramesh (Chandra)

DCH (UK ),  MD , Dip NB  , DM (Medical Oncology ), MSc Oncology (UK ), MBA , PhD

Professor and Head Medical Oncology
Saveetha Medical College Hospital.  Saveetha University . Chennai

Senior Consultant Medical and Paediatric oncology Apollo speciality hospital , Sanker Netarlaya , HCG Cancer Centre. Chennai

Founder, CEO and Managing TrusteeFreedom from Cancer Research and Relief Foundation. Public trust

TEL:  919840758567, 7811958567

About Admin

Check Also

Septuagenarian Woman Walks after successfully treated for a Complex Hip Surgery at Fortis Malar Hospital

Chennai, 2019 :  A team of doctors at Fortis Malar Hospital successfully performed a successful complex Revision …

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.